The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into ...
The Joint Corp. (NASDAQ: JYNT) is a healthcare company headquartered in Scottsdale, Arizona, focused on making chiropractic care accessible, affordable, and consumer-friendly. Founded originally in 1999 by a chiropractor, the company was refounded in 2010 with a retail healthcare model, and has since grown into the nation's largest franchisor of ...The Joint Corp. (NASDAQ: JYNT) is a healthcare company headquartered in Scottsdale, Arizona, focused on making chiropractic care accessible, affordable, and consumer-friendly. Founded originally in 1999 by a chiropractor, the company was refounded in 2010 with a retail healthcare model, and has since grown into the nation's largest franchisor of chiropractic clinics, operating under The Joint Chiropractic brand. As of December 2025, the network comprised approximately 960 active clinics across the United States, a mix of corporate-owned and franchised locations. The company employs a multi-pronged expansion strategy: direct company ownership, management agreements, franchising, and regional development partnerships. This hybrid model allows for rapid scaling while managing capital intensity. In terms of products and services, The Joint offers routine chiropractic adjustments, spinal decompression, and therapeutic exercises. Its core service is a subscription-based model where patients pay a monthly fee for unlimited adjustments, eliminating the need for insurance, which simplifies the patient experience and encourages regular visits. The company's revenue streams include company-owned clinic sales, franchise royalties and fees, and product sales (e.g., supplements). Financially, as of the latest TTM data, The Joint generated revenue per share of $4.11, with a gross profit margin of approximately 81%, reflecting the high-margin nature of chiropractic services. However, net profit margin was around 6.5%, indicating significant operating expenses, particularly in sales, general, and administrative costs (75.7% of revenue). The company has a strong balance sheet with a current ratio of 1.83 and minimal debt, and trades at a price-to-earnings ratio of about 32.5. Recently, The Joint has focused on refranchising company-owned clinics to accelerate growth and improve profitability. Leadership is headed by CEO Sanjiv Razdan, who joined in 2024 with extensive experience in franchising and hospitality. The company's mission is to improve quality of life through routine and affordable chiropractic care, and it continues to invest in brand awareness and clinic expansion. Despite competitive pressure from other alternative healthcare providers, The Joint remains a pioneer in integrating chiropractic care into a retail-like consumer model.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$54.9M
+5.2%
+2.4%
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$2.9M
+150.2%
-49.7%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
+79.6%
+2.1%
+6.0%
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
-1.6%
+54.5%
-140.0%
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
+5.3%
+147.7%
-50.9%
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$334724
-95.9%
+213.2%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
+0.6%
-96.1%
+210.5%
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
13.3%
+246.8%
-2.6%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
1.59x
+4.4%
+13.2%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
Operator: Thank you for standing by. My name is Rebecca, and I will be your conference operator today. At this time, I would like to welcome everyone to The Joint Corporation Second Quarter 2026 Financial Results Conference Call. [Operator Instructions] I will now turn the call over to Richard Land with Alliance Advisors Investor Relations. Please go ahead.
Richard Land: Thank you, Rebecca, and good afternoon, everyone. Joining us on the call today are President and CEO, Sanjiv Razdan; and CFO, Scott Bowman. Please note we are using a slide presentation that can be found on The Joint's Investor Relations website. This afternoon, The Joint Corp issued a press release for the second quarter ended June 30, 2026. If you do not already have a copy, it can also be found on the company's website. Please be advised that today's discussion, including any financial and related guidance to be provided, consists of forward-looking statements as defined by securities laws. These statements are based on information currently available to us and involve risks and uncertainties that could cause actual future results, performance and business prospects and opportunities to differ materially from those expressed in or implied by these statements. Some important factors that could cause such differences are discussed in the risk factor section of The Joint Corp's filing with the Securities and Exchange Commission. Forward-looking statements speak only as of the date the statements are made, and the company assumes no obligation to update them except to the extent required by applicable securities laws. Management uses non-GAAP financial measures such as EBITDA, adjusted EBITDA, free cash flow, and system-wide sales. A description of these measures is included in the press release issued earlier this afternoon, and reconciliations to the most directly comparable GAAP measures are included in the appendix to the presentation and press release, both of which are available in the investors tab of our website. With that, I'll now turn the call over to Sanjiv Razdan. Sanjiv, please go ahead.
Sanjiv Razdan: Thank you, Richard. Good afternoon, everyone. The second quarter was a period of continued execution of our Joint 2.0 initiative, with our results reflecting the progress we are making toward a stronger, more profitable financial profile as a capital-light, pure-play franchisor. This was underscored by a $560,000 year-over-year improvement in consolidated net income and a $1.4 million increase in adjusted EBITDA from continuing operations, reflecting the improved operating leverage of the current business. Meanwhile, we delivered 152% year-over-year growth in cash flow from operating activities, resulting in a $1.6 million increase in free cash flow. These improvements were driven by continued progress on our refranchising initiative, disciplined capital allocation, and significant improvement in our patient retention levels. First, on refranchising, our 3 previously …
